UNCOVERED: 2 - The Untold Story

FDA Clears a New Class of Myeloma Drug for Patients Whose Cancer Returned After Earlier Treatment

The FDA granted accelerated approval to iberdomide, the first CELMoD for relapsed multiple myeloma, usable as early as first relapse.

Medical Daily · Aug 17

Cancer Patients Now Wait About 10 Days Longer to Start Treatment Than They Did a Decade Ago

A JAMA Surgery study of more than 2.7 million patients found that wait times from cancer diagnosis to first treatment rose across all six cancers studied.

Medical Daily · Aug 14

Relay Therapeutics Stock Is Up Nearly 500% Over the Past Year

Relay Therapeutics (RLAY) is a clinical-stage precision medicines company focused on targeted oncology, with a $4.4 billion market cap. RLAY has surged 486% over the past year. Shares are trading near a new 3-year high. Technical momentum is strong, but fundamentals show that revenue is expected to decrease by more...

Barchart · Aug 13

Cervical Cancer Is Almost Entirely Preventable. So Why Does It Still Kill So Many Women in India

Numbers That Should Not ExistEvery eight minutes, an Indian woman dies of cervical cancer. That figure comes from ICMR data published in its National Cancer Registry Programme report, and it has not moved in the direction it should. India records roughly 1.25 lakh new cervical cancer cases annually and accounts…

Times Life · Aug 5

FDA Tells Cancer Trial Sponsors to Stop Copying Eligibility Rules That Lack Scientific Support

FDA finalized three guidances telling cancer trial sponsors to justify lab value, performance status, and washout period exclusions rather than copying them.

Medical Daily · Aug 4

8 Oral Cancer Warning Symptoms Indian Men Keep Ignoring, From Lesions to Screening Delays

A White Patch That Will Not Go AwayLeukoplakia, a thick white or greyish patch inside the mouth, is one of the most documented precancerous lesions in Indian men who use smokeless tobacco. A 2020 study published in the Indian Journal of Cancer found that leukoplakia was present in nearly 60%…

Times Life · Aug 4

Myeloma's Most Effective New Drugs Require a Hospital Stay to Start, and That Is Keeping Them Out of Reach for Rural Patients

Bispecific antibodies work in advanced myeloma, but startup requirements keep them at academic centers. New guidance aims to close the community gap.

Medical Daily · Jul 31

FDA Renamed and Updated Its Companion Diagnostics List, Including the First Test That Detects Cancer's Return in Blood

FDA updated its companion diagnostics list on July 23, adding tests that decide who gets targeted cancer drugs, including a blood-based MRD test.

Medical Daily · Jul 31

Andhra Pradesh teams up with AstraZeneca for next-gen cancer care model

Andhra Pradesh signed an MoU with AstraZeneca for an integrated precision oncology ecosystem. This initiative will integrate artificial intelligence and advanced genomics for cancer care. The collaboration aims to transform patient journeys from screening to follow-up. AstraZeneca will deploy AI-powered solutions for early lung cancer detection. An Integrated Genomic Solutions…

The Economic Times · Jul 28

FDA Approves Revtorpyk for a Breast Cancer Subgroup That Had Been Left Out of Targeted Treatment

FDA approved Revtorpyk (gedatolisib) for HR+/HER2- PIK3CA wild-type advanced breast cancer. VIKTORIA-1 showed 9.3 months of PFS versus 2.0.

Medical Daily · Jul 27